Request Deal Involvement
Ascend Gene and Cell Therapies completed the acquisition of Freeline Therapeutics from Freeline Therapeutics Holdings for $25m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Torreya Capital
or
Principals
bidder
ASCEND GENE AND CELL THERAPIES
target
FREELINE THERAPEUTICS (GERMAN SUBSIDIARY)
vendor
FREELINE THERAPEUTICS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite